View ValuationPaltac 将来の成長Future 基準チェック /16Paltac利益と収益がそれぞれ年間4.3%と3.3%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に7.6% 4.4%なると予測されています。主要情報4.3%収益成長率4.44%EPS成長率Retail Distributors 収益成長24.9%収益成長率3.3%将来の株主資本利益率7.60%アナリストカバレッジLow最終更新日11 May 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Jul 14Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)お知らせ • Jul 08MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. As of June 19, 2026, S.T. Corporation has resolved to tender its 339,000 shares. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation. MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders on July 7, 2026. A total of 24,466,104 shares were tendered, which was above the minimum number of shares to be purchased (8,676,100 shares). MediPal Holdings Corporation plans to implement a series of procedures to make the Tender Offeror the sole shareholder of Paltac Corporation (the “Squeeze-out Procedures”). Upon completion, the shares of Paltac Corporation will be delisted from the Prime Market of the Tokyo Stock Exchange.お知らせ • Jun 19Paltac Corporation Announces Management ChangesPaltac Corporation announced that, at a meeting of the Board of Directors held on June 19, 2026, it resolved to make changes in its directors and executive officers. Masahiro Noma was redesignated from Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters to Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters, General Manager of Logistics Headquarters. Masashi Gotan retired from the position of Executive Officer, General Manager of Logistics Headquarters and was attached to the General Affairs Headquarters.お知らせ • Jun 09Paltac Corporation to Report Q1, 2027 Results on Aug 03, 2026Paltac Corporation announced that they will report Q1, 2027 results on Aug 03, 2026お知らせ • May 12MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation.お知らせ • May 11Paltac Corporation, Annual General Meeting, Jun 19, 2026Paltac Corporation, Annual General Meeting, Jun 19, 2026.お知らせ • May 10Paltac Corporation to Report Fiscal Year 2026 Results on May 11, 2026Paltac Corporation announced that they will report fiscal year 2026 results on May 11, 2026お知らせ • Dec 02Paltac Corporation to Report Q3, 2026 Results on Feb 06, 2026Paltac Corporation announced that they will report Q3, 2026 results on Feb 06, 2026お知らせ • Sep 02Paltac Corporation to Report Q2, 2026 Results on Nov 04, 2025Paltac Corporation announced that they will report Q2, 2026 results on Nov 04, 2025業績と収益の成長予測OTCPK:PCCO.F - アナリストの将来予測と過去の財務データ ( )JPY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/20291,369,50025,176N/A27,57613/31/20281,314,50623,53419,92024,33233/31/20271,270,58823,53219,23923,53813/31/20261,237,84622,03122,60924,929N/A12/31/20251,227,66921,90217,12119,447N/A9/30/20251,212,80522,10519,10221,331N/A6/30/20251,201,23023,02817,49819,127N/A3/31/20251,188,09722,86419,05320,675N/A12/31/20241,179,98821,77620,48122,245N/A3/31/20241,151,96620,63820,98626,790N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: PCCO.Fの予測収益成長率 (年間4.3% ) は 貯蓄率 ( 3.5% ) を上回っています。収益対市場: PCCO.Fの収益 ( 4.3% ) US市場 ( 17.8% ) よりも低い成長が予測されています。高成長収益: PCCO.Fの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: PCCO.Fの収益 ( 3.3% ) US市場 ( 12.8% ) よりも低い成長が予測されています。高い収益成長: PCCO.Fの収益 ( 3.3% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: PCCO.Fの 自己資本利益率 は、3年後には低くなると予測されています ( 7.6 %)。成長企業の発掘7D1Y7D1Y7D1YRetail 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/23 20:12終値2026/05/11 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Paltac Corporation 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Oliver James Gray MatthewCLSAYumiko KaiIchiyoshi Research Institute Inc.Kyoichiro ShigemuraNomura Securities Co. Ltd.1 その他のアナリストを表示
お知らせ • Jul 14Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)
お知らせ • Jul 08MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. As of June 19, 2026, S.T. Corporation has resolved to tender its 339,000 shares. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation. MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders on July 7, 2026. A total of 24,466,104 shares were tendered, which was above the minimum number of shares to be purchased (8,676,100 shares). MediPal Holdings Corporation plans to implement a series of procedures to make the Tender Offeror the sole shareholder of Paltac Corporation (the “Squeeze-out Procedures”). Upon completion, the shares of Paltac Corporation will be delisted from the Prime Market of the Tokyo Stock Exchange.
お知らせ • Jun 19Paltac Corporation Announces Management ChangesPaltac Corporation announced that, at a meeting of the Board of Directors held on June 19, 2026, it resolved to make changes in its directors and executive officers. Masahiro Noma was redesignated from Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters to Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters, General Manager of Logistics Headquarters. Masashi Gotan retired from the position of Executive Officer, General Manager of Logistics Headquarters and was attached to the General Affairs Headquarters.
お知らせ • Jun 09Paltac Corporation to Report Q1, 2027 Results on Aug 03, 2026Paltac Corporation announced that they will report Q1, 2027 results on Aug 03, 2026
お知らせ • May 12MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation.
お知らせ • May 11Paltac Corporation, Annual General Meeting, Jun 19, 2026Paltac Corporation, Annual General Meeting, Jun 19, 2026.
お知らせ • May 10Paltac Corporation to Report Fiscal Year 2026 Results on May 11, 2026Paltac Corporation announced that they will report fiscal year 2026 results on May 11, 2026
お知らせ • Dec 02Paltac Corporation to Report Q3, 2026 Results on Feb 06, 2026Paltac Corporation announced that they will report Q3, 2026 results on Feb 06, 2026
お知らせ • Sep 02Paltac Corporation to Report Q2, 2026 Results on Nov 04, 2025Paltac Corporation announced that they will report Q2, 2026 results on Nov 04, 2025